{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:10:14Z","timestamp":1789135814374,"version":"build-2803163510"},"reference-count":39,"publisher":"American Chemical Society (ACS)","issue":"9","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["222153\/Z\/20\/Z"],"award-info":[{"award-number":["222153\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\u201cPathogen-hopping\u201d is an approach in infectious disease research with potential to expedite drug discovery. This is done by testing agents which are active against one or more pathogens in a new pathogen, exploiting the fact that orthologues of protein targets essential for survival exist across different pathogens. In some cases, these compounds possess selectivity versus the human orthologue, further aiding the process. To identify new lead compounds for our schistosomiasis drug discovery program, we adopted this approach by first mining the literature to find antimalarial compounds which had not been evaluated against Schistosoma. Next, a filtering process was applied to remove undesirable or potentially toxic compounds. The triaged set of compounds was then screened against Schistosoma mansoni schistosomula and adult worms. Two chemotypes displayed schistosomula and adult worm paralysis activity. Hit assessment was completed for one of these multistage actives to assess its potential for development as an antischistosomal treatment.<\/jats:p>","DOI":"10.1021\/acsinfecdis.6c00446","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:28:13Z","timestamp":1788287293000},"page":"2985-2994","source":"Crossref","is-referenced-by-count":0,"title":["A Pathogen-Hopping Approach for the Identification\nof Compounds with Multistage Antischistosomal Activity"],"prefix":"10.1021","volume":"12","author":[{"given":"Malcolm G.","family":"Taylor","sequence":"first","affiliation":[{"name":"University of Dundee , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Mendonca Matos Day","sequence":"additional","affiliation":[{"name":"University of Dundee , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Lees","sequence":"additional","affiliation":[{"name":"Aberystwyth University , , ,","place":["Aberystwyth, Wales, SY23 3DA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1049-4185","authenticated-orcid":true,"given":"Nicola","family":"Caldwell","sequence":"additional","affiliation":[{"name":"University of Dundee , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine E.","family":"Forde-Thomas","sequence":"additional","affiliation":[{"name":"Aberystwyth University , , ,","place":["Aberystwyth, Wales, SY23 3DA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Hulme","sequence":"additional","affiliation":[{"name":"Aberystwyth University , , ,","place":["Aberystwyth, Wales, SY23 3DA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Evans","sequence":"additional","affiliation":[{"name":"Aberystwyth University , , ,","place":["Aberystwyth, Wales, SY23 3DA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Read","sequence":"additional","affiliation":[{"name":"University of Dundee , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5238-1314","authenticated-orcid":true,"given":"Ian H.","family":"Gilbert","sequence":"additional","affiliation":[{"name":"University of Dundee , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3932-5502","authenticated-orcid":true,"given":"Karl F.","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Aberystwyth University , , ,","place":["Aberystwyth, Wales, SY23 3DA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0959-1113","authenticated-orcid":true,"given":"Beatriz","family":"Baragan\u0303a","sequence":"additional","affiliation":[{"name":"University of Dundee , , ,","place":["Dundee, U.K., DD1 5EH"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"issue":"10479","key":"2026091109094937100_cit1","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S0140-6736(24)02814-9","article-title":"Human Schistosomiasis","volume":"405","author":"Buonfrate","year":"2025","journal-title":"Lancet"},{"issue":"1","key":"2026091109094937100_cit2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-018-0013-8","article-title":"Schistosomiasis","volume":"4","author":"McManus","year":"2018","journal-title":"Nat. Rev. Dis.\nPrimers"},{"issue":"9936","key":"2026091109094937100_cit3","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","article-title":"Human Schistosomiasis","volume":"383","author":"Colley","year":"2014","journal-title":"Lancet"},{"issue":"5","key":"2026091109094937100_cit4","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1021\/acsinfecdis.3c00081","article-title":"Perspective on Schistosomiasis\nDrug\nDiscovery: Highlights from a Schistosomiasis Drug Discovery Workshop\nat Wellcome Collection, London, September 2022","volume":"9","author":"Caldwell","year":"2023","journal-title":"ACS Infect. Dis."},{"key":"2026091109094937100_cit5","doi-asserted-by":"publisher","first-page":"933097","DOI":"10.3389\/fitd.2022.933097","article-title":"A Review\nof the Genetic Determinants of Praziquantel Resistance in Schistosoma\nMansoni: Is Praziquantel and Intestinal Schistosomiasis a Perfect\nMatch?","volume":"3","author":"Summers","year":"2022","journal-title":"Front. Trop. Dis."},{"issue":"7","key":"2026091109094937100_cit6","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1080\/20477724.2022.2145070","article-title":"Praziquantel Efficacy, Urinary and\nIntestinal Schistosomiasis\nReinfection \u2013 a Systematic Review","volume":"117","author":"Aboagye","year":"2023","journal-title":"Pathog.\nGlobal Health"},{"key":"2026091109094937100_cit7","doi-asserted-by":"publisher","DOI":"10.1101\/2024.08.29.610291","article-title":"Extensive\nTransmission and Variation in a Functional Receptor for Praziquantel\nResistance in Endemic Schistosoma mansoni","author":"Berger","year":"2024","journal-title":"bioRxiv"},{"issue":"7","key":"2026091109094937100_cit8","doi-asserted-by":"publisher","first-page":"e0009490","DOI":"10.1371\/journal.pntd.0009490","article-title":"The Discovery\nof a Novel Series of Compounds with Single-Dose Efficacy against Juvenile\nand Adult Schistosoma Species","volume":"15","author":"Gardner","year":"2021","journal-title":"PLoS Neglected\nTrop. Dis."},{"key":"2026091109094937100_cit9","doi-asserted-by":"publisher","first-page":"113823","DOI":"10.1016\/j.ejmech.2021.113823","article-title":"Anti-Schistosomal Activities of Quinoxaline-Containing\nCompounds: From Hit Identification to Lead Optimisation","volume":"226","author":"Padalino","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"2026091109094937100_cit10","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s41594-024-01298-3","article-title":"Target-Based Discovery\nof a Broad-Spectrum Flukicide","volume":"31","author":"Sprague","year":"2024","journal-title":"Nat. Struct.\nMol. Biol."},{"issue":"5","key":"2026091109094937100_cit11","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1021\/acsinfecdis.4c00020","article-title":"Dual Strategy\nto Design New Agents\nTargeting Schistosoma Mansoni: Advancing Phenotypic and SmCB1 Inhibitors\nfor Improved Efficacy","volume":"10","author":"Fuchs","year":"2024","journal-title":"ACS Infect. Dis."},{"issue":"11","key":"2026091109094937100_cit12","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1021\/acsmedchemlett.2c00248","article-title":"Identification\nof Inhibitors of the Schistosoma Mansoni VKR2 Kinase Domain","volume":"13","author":"Mathavan","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"2026091109094937100_cit13","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1038\/s41467-023-39444-y","article-title":"Non-Covalent\nInhibitors of Thioredoxin Glutathione Reductase with Schistosomicidal\nActivity in Vivo","volume":"14","author":"Petukhova","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"2026091109094937100_cit14","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/s41598-024-52018-2","article-title":"Fragment Library\nScreening by X-Ray Crystallography and Binding Site Analysis on Thioredoxin\nGlutathione Reductase of Schistosoma Mansoni","volume":"14","author":"de Souza Neto","year":"2024","journal-title":"Sci. Rep."},{"issue":"15","key":"2026091109094937100_cit15","doi-asserted-by":"publisher","first-page":"7075","DOI":"10.1021\/acs.jmedchem.5b02038","article-title":"Discovery of New Anti-Schistosomal Hits by Integration\nof QSAR-Based Virtual Screening and High Content Screening","volume":"59","author":"Neves","year":"2016","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026091109094937100_cit16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1186\/s13071-015-1023-y","article-title":"Repurposing of Anticancer\nDrugs: In Vitro and in Vivo\nActivities against Schistosoma Mansoni","volume":"8","author":"Cowan","year":"2015","journal-title":"Parasities\nVectors"},{"issue":"1","key":"2026091109094937100_cit17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/ph11010015","article-title":"Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules","volume":"11","author":"Gouveia","year":"2018","journal-title":"Pharmaceuticals"},{"issue":"1","key":"2026091109094937100_cit18","doi-asserted-by":"publisher","first-page":"e2610","DOI":"10.1371\/journal.pntd.0002610","article-title":"Orally Active Antischistosomal Early Leads Identified\nfrom the Open Access Malaria Box","volume":"8","author":"Ingram-Sieber","year":"2014","journal-title":"PLoS Neglected\nTrop. Dis."},{"issue":"1","key":"2026091109094937100_cit19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1021\/acsinfecdis.8b00220","article-title":"Early Antischistosomal Leads Identified\nfrom in Vitro and in Vivo Screening of the Medicines for Malaria Venture\nPathogen Box","volume":"5","author":"Pasche","year":"2019","journal-title":"ACS Infect. Dis."},{"issue":"6","key":"2026091109094937100_cit20","doi-asserted-by":"publisher","first-page":"e0009511","DOI":"10.1371\/journal.pntd.0009511","article-title":"Evidence for\nin Vitro and in Vivo\nActivity of the Antimalarial Pyronaridine against Schistosoma","volume":"15","author":"Koehne","year":"2021","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"2","key":"2026091109094937100_cit21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00436-010-2080-y","article-title":"Effect of\nMefloquine Administered Orally at Single,\nMultiple, or Combined with Artemether, Artesunate, or Praziquantel\nin Treatment of Mice Infected with Schistosoma Japonicum","volume":"108","author":"Xiao","year":"2011","journal-title":"Parasitol. Res."},{"issue":"7","key":"2026091109094937100_cit22","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ijpara.2013.01.007","article-title":"First Insight\ninto the Effect of Single Oral Dose Therapy\nwith Artemisinin\u2013Naphthoquine Phosphate Combination in a Mouse\nModel of Schistosoma mansoni Infection","volume":"43","author":"El-Beshbishi","year":"2013","journal-title":"Int. J. Parasitol."},{"issue":"2","key":"2026091109094937100_cit23","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00436-010-2084-7","article-title":"Schistosoma\nJaponicum-Infected Hamsters (Mesocricetus\nAuratus) Used as a Model in Experimental Chemotherapy with Praziquantel,\nArtemether, and OZ Compounds","volume":"108","author":"Xiao","year":"2011","journal-title":"Parasitol. Res."},{"issue":"2","key":"2026091109094937100_cit24","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1128\/AAC.05371-11","article-title":"In Vivo Activity of Aryl Ozonides\nagainst Schistosoma Species","volume":"56","author":"Keiser","year":"2012","journal-title":"Antimicrob. Agents\nChemother."},{"issue":"4","key":"2026091109094937100_cit25","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1128\/AAC.01537-06","article-title":"In Vitro and In Vivo\nActivities of Synthetic Trioxolanes against Major Human Schistosome\nSpecies","volume":"51","author":"Xiao","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"14","key":"2026091109094937100_cit26","doi-asserted-by":"publisher","first-page":"7015","DOI":"10.1073\/pnas.1814685116","article-title":"Lysyl-TRNA Synthetase as a Drug Target\nin Malaria and Cryptosporidiosis","volume":"116","author":"Baragan\u0303a","year":"2019","journal-title":"Proc. Natl.\nAcad. Sci. U.S.A."},{"issue":"1","key":"2026091109094937100_cit27","doi-asserted-by":"publisher","first-page":"5992","DOI":"10.1038\/s41467-022-33736-5","article-title":"Lysyl-TRNA Synthetase, a Target for\nUrgently Needed\nM. Tuberculosis Drugs","volume":"13","author":"Green","year":"2022","journal-title":"Nat. Commun."},{"issue":"770","key":"2026091109094937100_cit28","doi-asserted-by":"publisher","first-page":"eadm8631","DOI":"10.1126\/scitranslmed.adm8631","article-title":"Cryptosporidium Lysyl-TRNA Synthetase Inhibitors Define\nthe Interplay between Solubility and Permeability Required to Achieve\nEfficacy","volume":"16","author":"Caldwell","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"6419","key":"2026091109094937100_cit29","doi-asserted-by":"publisher","first-page":"eaat9446","DOI":"10.1126\/science.aat9446","article-title":"Open-Source Discovery\nof Chemical Leads for next-Generation Chemoprotective Antimalarials","volume":"362","author":"Antonova-Koch","year":"2018","journal-title":"Science"},{"issue":"17\u201318","key":"2026091109094937100_cit30","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.drudis.2011.06.001","article-title":"Getting Physical\nin Drug Discovery II: The Impact of Chromatographic Hydrophobicity\nMeasurements and Aromaticity","volume":"16","author":"Young","year":"2011","journal-title":"Drug Discovery\nToday"},{"issue":"10","key":"2026091109094937100_cit31","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.drudis.2016.07.007","article-title":"Quality Guidelines\nfor Oral Drug\nCandidates: Dose, Solubility and Lipophilicity","volume":"21","author":"Bayliss","year":"2016","journal-title":"Drug Discovery Today"},{"key":"2026091109094937100_cit32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.poly.2014.11.040","article-title":"Solution Equilibria Studies of Complexes of Divalent Metal Ions with\n2-Aminophenol and 3,4-Dihydroxybenzoic Acid","volume":"88","author":"Chandra","year":"2015","journal-title":"Polyhedron"},{"issue":"6061","key":"2026091109094937100_cit33","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1126\/science.1211936","article-title":"Imaging of Plasmodium\nLiver Stages to Drive Next-Generation Antimalarial Drug Discovery","volume":"334","author":"Meister","year":"2011","journal-title":"Science"},{"issue":"9","key":"2026091109094937100_cit34","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1128\/AAC.02727-13","article-title":"KAF156 Is an Antimalarial\nClinical Candidate with Potential for Use in Prophylaxis, Treatment,\nand Prevention of Disease Transmission","volume":"58","author":"Kuhen","year":"2014","journal-title":"Antimicrob.\nAgents Chemother."},{"key":"2026091109094937100_cit35","doi-asserted-by":"publisher","first-page":"16166","DOI":"10.1038\/nmicrobiol.2016.166","article-title":"UDP-Galactose\nand Acetyl-CoA Transporters as Plasmodium Multidrug Resistance Genes","volume":"1","author":"Lim","year":"2016","journal-title":"Nat. Microbiol."},{"issue":"7","key":"2026091109094937100_cit36","doi-asserted-by":"publisher","first-page":"e1762","DOI":"10.1371\/journal.pntd.0001762","article-title":"Whole Organism High-Content Screening by Label-Free,\nImage-Based Bayesian Classification for Parasitic Diseases","volume":"6","author":"Paveley","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"2","key":"2026091109094937100_cit37","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ijpddr.2017.03.007","article-title":"Novel Carbazole Aminoalcohols\nas Inhibitors of \u03b2-Hematin Formation: Antiplasmodial and Antischistosomal\nActivities","volume":"7","author":"Wang","year":"2017","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"issue":"15","key":"2026091109094937100_cit38","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.1016\/j.bmcl.2009.06.001","article-title":"Tetrahydrocarbazole\nAmides with Potent Activity against Human Papillomaviruses","volume":"19","author":"Gudmundsson","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"9","key":"2026091109094937100_cit39","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1021\/jm300041e","article-title":"Imidazolopiperazines:\nLead Optimization of the Second-Generation Antimalarial Agents","volume":"55","author":"Nagle","year":"2012","journal-title":"J. Med. Chem."}],"container-title":["ACS Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsinfecdis.6c00446","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article-pdf\/12\/9\/2985\/67491850\/acsinfecdis.6c00446.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article-pdf\/12\/9\/2985\/67491850\/acsinfecdis.6c00446.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:36:58Z","timestamp":1789133818000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article\/12\/9\/2985\/5337493\/A-Pathogen-Hopping-Approach-for-the-Identification"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,8,27]]},"published-print":{"date-parts":[[2026,9,11]]}},"URL":"https:\/\/doi.org\/10.1021\/acsinfecdis.6c00446","relation":{},"ISSN":["2373-8227"],"issn-type":[{"value":"2373-8227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]}}}